Intuitive Surgical, Inc. $ISRG Shares Purchased by Next Century Growth Investors LLC

Next Century Growth Investors LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 64.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,343 shares of the medical equipment provider’s stock after purchasing an additional 4,453 shares during the quarter. Next Century Growth Investors LLC’s holdings in Intuitive Surgical were worth $5,618,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of ISRG. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the period. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth approximately $26,000. Global Financial Private Client LLC raised its stake in shares of Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the first quarter worth approximately $26,000. Finally, LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the first quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.7%

ISRG opened at $471.15 on Thursday. The firm has a market cap of $168.90 billion, a P/E ratio of 65.71, a PEG ratio of 4.97 and a beta of 1.59. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business’s fifty day simple moving average is $501.89 and its 200 day simple moving average is $519.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.78 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the sale, the insider directly owned 18,520 shares of the company’s stock, valued at approximately $9,171,844.80. This trade represents a 13.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,839 shares of company stock valued at $7,896,972 over the last quarter. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ISRG shares. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Truist Financial raised their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.